Related Experiment Video
Updated: Aug 6, 2025

Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes
Published on: January 27, 2023
CD115- monocytic myeloid-derived suppressor cells are precursors of OLFM4high polymorphonuclear myeloid-derived
Yunyun Zou1,2, Nobuhiko Kamada3, Seung-Yong Seong4,5
1Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
Abstract:
Myeloid-derived suppressor cells (MDSCs) consist of monocytic (M-) MDSCs and polymorphonuclear (PMN-) MDSCs that contribute to an immunosuppressive environment in tumor-bearing hosts. However, research on the phenotypic and functional heterogeneity of MDSCs in tumor-bearing hosts and across different disease stage is limited. Here we subdivide M-MDSCs based on CD115 expression and report that CD115- M-MDSCs are functionally distinct from CD115+ M-MDSCs. CD115- M-MDSCs increased in bone marrow and blood as tumors progressed. Transcriptome analysis revealed that CD115- M-MDSCs expressed higher levels of neutrophil-related genes. Moreover, isolated CD115- M-MDSCs had higher potential to be differentiated into PMN-MDSCs compared with CD115+ M-MDSCs. Of note, CD115- M-MDSCs were able to differentiate into both olfactomedin 4 (OLFM4)hi and OLFM4lo PMN-MDSCs, whereas CD115+ M-MDSCs differentiated into a smaller proportion of OLFM4lo PMN-MDSCs. In vivo, M-MDSC to PMN-MDSC differentiation occurred most frequently in bone marrow while M-MDSCs preferentially differentiated into tumor-associated macrophages in the tumor mass. Our study reveals the presence of previously unrecognized subtypes of CD115- M-MDSCs in tumor-bearing hosts and demonstrates their cellular plasticity during tumorigenesis.
Insights
Researchers discovered a new subtype of monocytic myeloid-derived suppressor cells (M-MDSCs) called CD115- M-MDSCs. These cells are distinct from CD115+ M-MDSCs and show increased plasticity during tumor progression.
Area of Science:
- Immunology
- Cancer Biology
- Cellular Plasticity
Background:
- Myeloid-derived suppressor cells (MDSCs) are crucial in creating an immunosuppressive tumor microenvironment.
- MDSCs comprise monocytic (M-MDSCs) and polymorphonuclear (PMN-MDSCs) subtypes.
- Limited understanding exists regarding MDSC heterogeneity in tumors and across disease stages.
Purpose of the Study:
- To investigate the phenotypic and functional heterogeneity of M-MDSCs in tumor-bearing hosts.
- To characterize distinct M-MDSC subsets based on CD115 expression.
- To explore the role of these subsets in tumor progression and MDSC differentiation.
Main Methods:
- Subdivision of M-MDSCs based on CD115 expression.
- Analysis of MDSC populations in bone marrow and blood during tumor progression.
- Transcriptome analysis to identify gene expression patterns.
- In vitro differentiation assays.
- In vivo studies to observe MDSC differentiation in different tissues.
Main Results:
- CD115- M-MDSCs were identified as functionally distinct from CD115+ M-MDSCs.
- CD115- M-MDSC populations increased in bone marrow and blood with tumor progression.
- CD115- M-MDSCs exhibited higher expression of neutrophil-related genes and greater differentiation potential into PMN-MDSCs.
- CD115- M-MDSCs could differentiate into both OLFM4hi and OLFM4lo PMN-MDSCs, while CD115+ M-MDSCs primarily yielded OLFM4lo PMN-MDSCs.
- In vivo, M-MDSC to PMN-MDSC differentiation was most common in bone marrow, and M-MDSCs differentiated into tumor-associated macrophages within the tumor.
Conclusions:
- A previously unrecognized subtype, CD115- M-MDSCs, exists in tumor-bearing hosts.
- CD115- M-MDSCs display significant cellular plasticity during tumorigenesis.
- These findings reveal novel insights into MDSC heterogeneity and their dynamic roles in cancer progression.
More Related Videos
07:21Identification and Isolation of Oligopotent and Lineage-committed Myeloid Progenitors from Mouse Bone Marrow
Published on: July 29, 2018
09:57Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
Published on: January 29, 2019